Telo Genomics Balance Sheet

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	0.98	0.79	0.8	2.67	2.69	3.64
Cash & Short-Term Investments	0.98	0.79	0.8	2.67	2.69	3.64
Cash Growth	-21.88%	-0.84%	-70.22%	-0.73%	-25.95%	294.85%
Accounts Receivable	0.03	0.03	0.03	0.06	0.04	0.1
Other Current Assets	0.02	0.08	0.09	0.11	0.06	0.03
Total Current Assets	1.03	0.89	0.92	2.84	2.79	3.76
Net Property, Plant & Equipment	0.19	0.02	0.03	0.07	0.03	0.06
Other Intangible Assets	-	-	0.02	0.02	0.02	0.02
Total Assets	1.22	0.91	0.97	2.93	2.83	3.84
Accounts Payable	0.88	0.4	0.38	0.28	0.19	0.11
Short-Term Debt	1.18	-	-	-	-	-
Current Portion of Leases	0.05	-	-	-	-	-
Total Current Liabilities	2.11	0.4	0.38	0.28	0.19	0.11
Long-Term Debt	-	-	-	0.03	0.04	0.04
Long-Term Leases	0.08	-	-	-	-	-
Total Long-Term Liabilities	0.08	-	-	0.03	0.04	0.04
Total Liabilities	2.19	0.4	0.38	0.31	0.23	0.15
Common Stock	24.62	24.57	22.35	21.69	19.11	18.23
Additional Paid-in Capital	6.58	6.49	6.07	6.04	5.79	5.64
Retained Earnings	-32.18	-30.55	-27.83	-25.12	-22.3	-20.19
Shareholders' Equity	-0.97	0.51	0.59	2.61	2.6	3.69
Total Liabilities & Equity	1.22	0.91	0.97	2.93	2.83	3.84
Total Debt	1.32	0	0	0.03	0.04	0.04
Net Cash (Debt)	-0.34	0.79	0.8	2.64	2.65	3.6
Net Cash Growth	-	-0.84%	-69.86%	-0.46%	-26.24%	308.24%
Net Cash Per Share	-0.00	0.01	0.01	0.04	0.04	0.08
Book Value	-0.97	0.51	0.59	2.61	2.6	3.69
Book Value Per Share	-0.01	0.01	0.01	0.04	0.04	0.08
Tangible Book Value	-0.97	0.51	0.57	2.6	2.59	3.67
Tangible Book Value Per Share	-0.01	0.01	0.01	0.04	0.04	0.08